Combined with our results, it is shown that taurine can inhibit NLRP3 inflammasome activated in the liver, and reduce the transcription level of inflammatory cytokines and the inflammatory response mediated by inflammatory cytokines, thereby inhibiting the liver inflammatory response of T2DM rats and alleviating liver injury. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.